Industry

Pearl Voice turns doctor-patient conversations into structured clinical notes and chart-ready documentation, reducing administrative burden enabling clinicians to focus on quality care LOS ANGELES–(BUSINESS WIRE)–#ArtificialIntelligence—Pearl, the global leader in dental AI solutions, today announced Pearl Voice, an AI assistant for clinical documentation designed specifically for dental practices. Pearl Voice automatically captures and transcribes doctor–patient interactions … [Read more…]

LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Needham Virtual Healthcare Conference on April 14, 2026 and will participate in a fireside chat at 12:45 pm ET. A live audio webcast of … [Read more…]

VILLEJUIF, France–(BUSINESS WIRE)–Orano today announced that Frederic Desdouits has been appointed Chief Executive Officer of its subsidiary Orano Med, a biotechnology company pioneering the development of targeted alpha therapies in oncology. Nicolas Maes, Chief Executive Officer of the Orano group, declared: “The extensive experience of Frederic Desdouits in the pharmaceutical industry, particularly in the biotechnology … [Read more…]

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced that its local subsidiary, Meiji Pharma Asia Pte. Ltd. (Headquarters: Singapore, Managing Director: Kensuke Hata) commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma’s presence and expand its business in the ASEAN … [Read more…]

LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees. The equity awards were granted on April 1, 2026 and … [Read more…]

Cases include patients who failed prior treatment attempts for in-stent restenosis and native vessel obstructions REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana® Thrombectomy Catheter System. The cases were performed across the company’s limited US … [Read more…]

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position and the revenues from its Named Patient Early Access Program as of March 31, 2026. Cash position as of … [Read more…]

New portfolio embeds AI across core FM workflows to move facilities teams from reactive overload to strategic impact GREENVILLE, S.C.–(BUSINESS WIRE)–ServiceChannel, the leading platform for the procurement and delivery of facilities services, today announced the launch of ServiceChannel AI, the AI operating system for facilities management that embeds intelligence directly where facilities work gets done. … [Read more…]

ALZ-507 Designed as Well-Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 Corrector ALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and Pharmacokinetic Profile that Supports Once-Daily Dosing ALZ-507 Broadens Alzheon’s Proprietary Precision Medicine Therapeutic Pipeline Targeting Disease Modification in Alzheimer’s Disease FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ALZ801—Alzheon, Inc., a clinical-stage biopharmaceutical company … [Read more…]

~Approximately 100 times faster, will accelerate solutions for drug discovery, finance, and other complex problems~ KAWASAKI, Japan–(BUSINESS WIRE)–#SBM–Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprietary quantum‑inspired combinatorial optimization computer. The new algorithm significantly improves the probability of obtaining an optimal solution or a … [Read more…]